Document is current

Article History

Received: 20 July 2022

Accepted: 24 March 2023

First Online: 4 April 2023

Declarations

:

: Data were de-identified and certified as fully compliant with US patient confidentiality requirements outlined in the Health Insurance Portability and Accountability Act (HIPAA). Since this study relied exclusively on de-identified patient records and did not involve the collection, use, or dissemination of individually identifiable data, institutional review board approval was not required as per HIPAA. All methods were carried out in accordance with relevant guidelines and regulations in the Declaration of Helsinki. The data that support the findings of this study are not publicly available online; administrative permissions to access the data were given by IQVIA™ under license.

: Not applicable.

: DM is an employee of Acadia Pharmaceuticals Inc.KKS, MM, ND, KS, PL, and WYC are employees of Analysis Group, Inc., a consultancy that received funding from Acadia Pharmaceuticals, Inc. to conduct this study.